170 related articles for article (PubMed ID: 32728705)
1. Number of metastatic lymph nodes and zones as prognostic factors in non-small-cell lung cancer.
Maniwa T; Ohmura A; Hiroshima T; Ike A; Kimura T; Nakamura H; Nakatsuka SI; Okami J; Higashiyama M
Interact Cardiovasc Thorac Surg; 2020 Sep; 31(3):305-314. PubMed ID: 32728705
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of the Number of Metastatic Lymph Nodes on the Eighth Edition of the TNM Classification of NSCLC.
Katsumata S; Aokage K; Ishii G; Nakasone S; Sakai T; Okada S; Miyoshi T; Tane K; Tsuboi M
J Thorac Oncol; 2019 Aug; 14(8):1408-1418. PubMed ID: 31055075
[TBL] [Abstract][Full Text] [Related]
3. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
4. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
Park S; Cho S; Yum SW; Kim K; Jheon S
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Currently Used Nodal Stage Classification with the Number of Metastatic Lymph Nodes and the Number of Metastatic Lymph Node Stations for Non-Small Cell Lung Cancer; Which of These Is the Best Prognostic Factor?
Citak N; Aksoy Y; Isgörücü Ö; Obuz C; Acikmese B; Buyukkale S; Metin M; Sayar A
Zentralbl Chir; 2020 Dec; 145(6):565-573. PubMed ID: 31648357
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of regional lymph-node distribution in patients with N1-positive non-small cell lung cancer: A retrospective single-center analysis.
Eichhorn F; Klotz LV; Muley T; Kobinger S; Winter H; Eichhorn ME
Lung Cancer; 2019 Dec; 138():95-101. PubMed ID: 31678832
[TBL] [Abstract][Full Text] [Related]
9. A Proposal for Combination of Lymph Node Ratio and Anatomic Location of Involved Lymph Nodes for Nodal Classification in Non-Small Cell Lung Cancer.
Ding X; Hui Z; Dai H; Fan C; Men Y; Ji W; Liang J; Lv J; Zhou Z; Feng Q; Xiao Z; Chen D; Zhang H; Yin W; Lu N; He J; Wang L
J Thorac Oncol; 2016 Sep; 11(9):1565-73. PubMed ID: 27223457
[TBL] [Abstract][Full Text] [Related]
10. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
[TBL] [Abstract][Full Text] [Related]
11. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
[TBL] [Abstract][Full Text] [Related]
12. Significance of accurate hilar and intrapulmonary lymph node examination and prognostication in stage IA-IIA non-small cell lung cancer, a retrospective cohort study.
Zhai W; Duan F; Zheng Y; Yan Q; Dai S; Chen T; Chen J; Wang J
World J Surg Oncol; 2020 Sep; 18(1):258. PubMed ID: 32998771
[TBL] [Abstract][Full Text] [Related]
13. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
14. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
15. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
16. Skip metastasis in nonsmall cell lung carcinoma: predictive markers and isolated tumor cells in N1 lymph nodes.
Prenzel KL; Baldus SE; Mönig SP; Tack D; Sinning JM; Gutschow CA; Grass G; Schneider PM; Dienes HP; Hölscher AH
Cancer; 2004 May; 100(9):1909-17. PubMed ID: 15112272
[TBL] [Abstract][Full Text] [Related]
17. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of examined mediastinal lymph node count in clinical N0 non-small cell lung cancer.
Kamigaichi A; Aokage K; Katsumata S; Ishii G; Wakabayashi M; Miyoshi T; Tane K; Samejima J; Tsuboi M
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35781338
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
20. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
